QR Kodea

PET imaging of mGluR5 in Alzheimer’s disease

Abstract Background Metabotropic glutamate subtype 5 receptors (mGluR5) modulate synaptic transmission and may constitute an important therapeutic target in Alzheimer’s disease (AD) by mediating the synaptotoxic action of amyloid-β oligomers. We utilized the positron emission tomography (PET) radiol...

Deskribapen osoa

Gorde:
Egile Nagusiak: Adam P. Mecca, Julia W. McDonald, Hannah R. Michalak, Tyler A. Godek, Joanna E. Harris, Erika A. Pugh, Emily C. Kemp, Ming-Kai Chen, Arash Salardini, Nabeel B. Nabulsi, Keunpoong Lim, Yiyun Huang, Richard E. Carson, Stephen M. Strittmatter, Christopher H. van Dyck
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2020-01-01
Saila:Alzheimer’s Research & Therapy
Gaiak:
mGluR5
Glutamate receptor
Alzheimer’s disease
[18F]FPEB
PET
Sarrera elektronikoa:https://doi.org/10.1186/s13195-020-0582-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak